Pipecuronium Bromide is used as a muscle relaxant during anesthesia and various surgical procedures.

Pipecuronium is a non-depolarizing neuromuscular blocking agent that produces skeletal muscle paralysis by inhibiting nerve impulse transmission at the neuromuscular junction. The paralysis develops in a predictable sequence, initially affecting the muscles of the eyelids, followed by the jaw (mastication muscles), limb muscles, abdominal muscles, laryngeal muscles, and finally the intercostal muscles and diaphragm.

These agents do not affect consciousness or pain perception. Pipecuronium works by competitively blocking acetylcholine at nicotinic receptors on the motor end plate, thereby reducing the response of muscles to nerve stimulation. The neuromuscular blockade produced by this drug can usually be reversed by anticholinesterase agents.

Intravenous (Adult)

• Initial dose: 80–100 mcg/kg.
• Subsequent doses: 10–20 mcg/kg.
• Initial dose following suxamethonium admin or in patients at high risk: 50–60 mcg/kg.
• Initial dose for caesarean section: 35 mcg/kg.

The effect of Pipecuronium may be reduced by cholinesterase activity and long-term use of carbamazepine, phenytoin, or corticosteroids. Its neuromuscular blocking effect may be enhanced when used with drugs that also have neuromuscular blocking properties, such as lidocaine, quinidine, verapamil, and aminoglycoside antibiotics.

Pipecuronium is contraindicated in patients with known hypersensitivity to the drug.

Possible adverse effects include transient hypotension, bradycardia, and reduced cardiac output.

Possible adverse effects include transient hypotension, bradycardia, and reduced cardiac output.

Use with caution in patients with pulmonary disease, respiratory insufficiency, asthma, neuromuscular disorders, dehydration, or in severely ill patients. Caution is also required in hepatic or renal impairment. In obese patients, dosage should be calculated based on ideal body weight. Use cautiously during pregnancy and lactation.

Overdose may result in prolonged apnea due to paralysis of respiratory muscles (intercostal muscles and diaphragm), along with cardiovascular collapse and effects related to histamine release.

Non-depolarizing muscle relaxant